Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Sichlau

Vascular & Interventional Radiology Hinsdale, IL Medical Doctor

NPI 1710927793 CMS profile 258918

911 N Elm St, Ste 128, Hinsdale, IL 60521

Open in the dashboard

General payments

$33,339

133 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$80,960

4 holdings reported · through program year 2025

Through program year 2025, Michael Sichlau of Hinsdale, IL is reported in the CMS Open Payments database as having received $33,339 across 133 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $80,960 across 4 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,179 20
2024 General $2,654 34
2023 General $1,431 17
2022 General $474 14
2021 General $577 11
2020 General $26,489 20
2019 General $535 17
2025 Ownership $11,730 1
2024 Ownership $11,730 1
2023 Ownership $20,000 1
2019 Ownership $37,500 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Sichlau
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Michael Sichlau were reported at $1,179. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Michael Sichlau Vascular & Interventional Radiology median Middle half National median
2019 $535 $422 $125–$1,555 $163
2020 $26,489 $200 $68–$652 $114
2021 $577 $280 $99–$866 $132
2022 $474 $433 $137–$1,497 $149
2023 $1,431 $506 $152–$2,019 $160
2024 $2,654 $556 $175–$1,930 $164
2025 $1,179 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Varian Medical Systems, Inc. $23,223 10 payments
  2. Boston Scientific Corporation $3,831 21 payments
  3. Inari Medical, Inc. $1,204 23 payments
  4. Siemens Medical Solutions USA, Inc. $1,034 11 payments
  5. Cook Incorporated $1,023 2 payments
  6. Penumbra, Inc. $323 3 payments
  7. AngioDynamics, Inc. $296 5 payments
  8. Stryker Corporation $235 6 payments
  9. Shockwave Medical, Inc $224 3 payments
  10. Medtronic, Inc. $202 8 payments
  11. Other $1,745 41 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $25,513 8 payments
  2. Food and Beverage $4,636 113 payments
  3. Travel and Lodging $3,189 12 payments
Products named General payments · program years 2019–2025
  1. Radiation Oncology $23,170 6 payments
  2. ICEfx $1,825 2 payments
  3. General - Therapies $1,406 7 payments
  4. CT THROMBECTOMY SYSTEM KIT $1,210 23 payments
  5. FLOWTRIEVER CATHETER, S $1,210 23 payments
  6. Gunther Tulip $1,023 2 payments
  7. Indigo System $242 2 payments
  8. SPYGLASS $236 3 payments
  9. TheraSphere Y90 Glass Microspheres 10 GBq $235 5 payments
  10. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter $224 3 payments
  11. Other $2,746 71 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

70

Median for Interventional Radiology: 38

Drug cost

$244

Median for Interventional Radiology: $333

Branded share of claims

0%

Median for Interventional Radiology: 53%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ciprofloxacin Hcl Generic 25 $89
Ibuprofen Generic 22 $86
Solifenacin Succinate Generic 23 $68

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 554 Part D prescribers listed as Interventional Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 126 billing codes

Paid by Medicare

$182,958

Of which drugs: $201

Medicare patients

382

Average age 75

Services billed

2,767

170 women, 212 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 55%
Ischemic heart disease 50%
Chronic kidney disease 44%
Diabetes 39%
Heart failure 33%
Atrial fibrillation 31%
Cancer 30%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 14 1,835 $201

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
POSLUMA
  • Blue Earth Diagnostics Limited $25
$25 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

133 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record